{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:00:45Z","timestamp":1776895245058,"version":"3.51.2"},"reference-count":30,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hull University Teaching Hospitals NHS Trust Research & Development Department"},{"name":"Renal Unit Charitable Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: Introducing haemodialysis (HD) treatment in a phased manner, with lower treatment times at the outset combined with pre-defined increments in treatment over a period of several weeks, reduces the early burden of treatment in patients with kidney failure and may help improve early outcomes. We have evaluated the feasibility of a novel transitional HD regime using a mixed-methods approach. Method: A single-centre cohort design was adopted, where participants were enrolled prospectively into an interventional arm and matched with historical controls. This paper reports on the feasibility of recruitment and retention in the prospective arm. People with kidney failure, starting HD treatment in out-patient settings, were recruited. They started HD on a transitional regime, with four pre-specified incremental steps (Phases 1 to 4), which aimed to establish participants on long-term 3\u00d7 weekly treatments over 14 weeks. Participants\u2019 experiences of starting HD in a phased manner were analysed using semi-structured interviews. Results: We screened 127 people over 18 months: eligible: 54 (43%); enrolled: 25 (46% of eligible). Fifteen started HD within the study timeframe; 14 were retained for 6 months. In 13 participants, the regime was altered (mostly during Phase 2) for clinical or scheduling reasons. Semi-structured interviews (n = 11) found participants overwhelmingly liked the phased HD introduction as an aid to becoming normalised to dialysis routines. Alterations to treatment were not associated with adverse experiences. Participants would highly recommend starting dialysis in this stepped and phased manner. Conclusions: It is feasible to enrol and retain participants in the proposed program of phased start of HD. The regime may be implemented flexibly in future trials. Starting dialysis on a less-than-three-times weekly basis was well received by participants. Trial Registration: Clinicaltrials.gov registration NCT04268264 (registered: 11 February 2020).<\/jats:p>","DOI":"10.3390\/healthcare14060792","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:49:58Z","timestamp":1774003798000},"page":"792","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phased Introduction of Haemodialysis in Patients with Kidney Failure: A Mixed-Methods Feasibility Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2423-0356","authenticated-orcid":false,"given":"Adil M.","family":"Hazara","sequence":"first","affiliation":[{"name":"Department of Renal Medicine, York Hospital, Wigginton Road, Clifton, York YO31 8HE, UK"},{"name":"Hull York Medical School, University of York, York YO10 5DD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3794-1598","authenticated-orcid":false,"given":"Maureen","family":"Twiddy","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Applied Health Research, University of Hull, Hull HU6 7RX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5228-2623","authenticated-orcid":false,"given":"Victoria","family":"Allgar","sequence":"additional","affiliation":[{"name":"Peninsula Clinical Trials Unit, Faculty of Health, University of Plymouth, Plymouth Science Park, Plymouth PL6 8BX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0996-9622","authenticated-orcid":false,"given":"Sunil","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Hull York Medical School, University of York, York YO10 5DD, UK"},{"name":"Academic Renal Research, Hull University Teaching Hospitals NHS Trust, Hull HU3 2JZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/sdi.12530","article-title":"Incremental Hemodialysis: How I Do It","volume":"29","author":"Golper","year":"2016","journal-title":"Semin. Dial."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.kint.2016.06.040","article-title":"Observations of twice a week hemodialysis","volume":"90","author":"Marshall","year":"2016","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ashby, D., Borman, N., Burton, J., Corbett, R., Davenport, A., Farrington, K., Flowers, K., Fotheringham, J., Fox, R.N.A., and Franklin, G. (2019). Renal Association Clinical Practice Guideline on Haemodialysis. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1527-3"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.ajkd.2014.04.019","article-title":"Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy","volume":"64","author":"Unruh","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40620-017-0391-0","article-title":"Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling","volume":"30","author":"Basile","year":"2017","journal-title":"J. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/MNH.0000000000000537","article-title":"Can incremental haemodialysis reduce early mortality rates in patients starting maintenance haemodialysis?","volume":"28","author":"Hazara","year":"2019","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/ndt\/gfp071","article-title":"Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose","volume":"24","author":"Vilar","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.kint.2016.05.028","article-title":"Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis","volume":"90","author":"Mathew","year":"2016","journal-title":"Kidney Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1159\/000013533","article-title":"Prescription of twice-weekly hemodialysis in the USA","volume":"19","author":"Hanson","year":"1999","journal-title":"Am. J. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/nep.13556","article-title":"Incremental and twice weekly haemodialysis in Australia and New Zealand","volume":"24","author":"Wolley","year":"2019","journal-title":"Nephrology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000334634","article-title":"Clinical outcome of twice-weekly hemodialysis patients in shanghai","volume":"33","author":"Lin","year":"2012","journal-title":"Blood Purif."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.xkme.2025.101238","article-title":"Incremental Hemodialysis Practices and Impact on Survival: Systematic Review and Meta-Analysis","volume":"8","author":"Hazara","year":"2026","journal-title":"Kidney Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/ndt\/gfz035","article-title":"Incremental haemodialysis and residual kidney function: More and more observations but no trials","volume":"34","author":"Basile","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/sdi.12701","article-title":"Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?","volume":"31","author":"Mathew","year":"2018","journal-title":"Semin. Dial."},{"key":"ref_15","unstructured":"Hull University Teaching Hospitals NHS Trust (HUTH) (2018). Statement of Purpose, HUTH."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s10157-021-02072-1","article-title":"A mixed-method feasibility study of a novel transitional regime of incremental haemodialysis: Study design and protocol","volume":"25","author":"Hazara","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000444815","article-title":"UK Renal Registry 18th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2014: National and Centre-specific Analyses","volume":"132","author":"Gilg","year":"2016","journal-title":"Nephron"},{"key":"ref_18","unstructured":"Hays, R.D., Kallich, J., Mapes, D., Coons, S., Amin, N., and Carter, W.B. (1995). Kidney Disease Quality of Life Short Form (KDQOL-SF \u2122), Version 1.3. A Manual for Use and Scoring, RAND."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: Extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"ref_20","unstructured":"Braun, V., and Clarke, V. (2013). First analytical steps: Fimiliarisation and coding. Successful Qualitative Research\u2014A Practical Guide for Beginners, Sage."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/17439760.2016.1262613","article-title":"Thematic analysis","volume":"12","author":"Clarke","year":"2017","journal-title":"J. Posit. Psychol."},{"key":"ref_22","unstructured":"National Institute for Health and Care Excellence (2021). Chronic Kidney Disease: Assessment and Management (NG 203), National Institute for Health and Care Excellence."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.ajkd.2016.05.022","article-title":"Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop","volume":"69","author":"Tong","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_24","unstructured":"Braun, V., and Clarke, V. (2013). Planning and designing qualitative research. Successful Qualitative Research\u2014A Practical Guide for Beginners, Sage."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Glasgow, R.E., Harden, S.M., Gaglio, B., Rabin, B., Smith, M.L., Porter, G.C., Ory, M.G., and Estabrooks, P.A. (2019). RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice with a 20-Year Review. Front. Public Health, 7.","DOI":"10.3389\/fpubh.2019.00064"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sattoe, J.N., Jedeloo, S., and van Staa, A. (2013). Effective peer-to-peer support for young people with end-stage renal disease: A mixed methods evaluation of Camp COOL. BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-279"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/1356389016652743","article-title":"Realist complex intervention science: Applying realist principles across all phases of the Medical Research Council framework for developing and evaluating complex interventions","volume":"22","author":"Fletcher","year":"2016","journal-title":"Evaluation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1681\/ASN.2016030340","article-title":"Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative","volume":"27","author":"Dember","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.kint.2019.01.017","article-title":"Dialysis initiation, modality choice, access, and prescription: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"96","author":"Chan","year":"2019","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ultrasmedbio.2019.10.018","article-title":"Ultrasound for the Clinical Management of Vascular Access Cannulation and Needle Position in Hemodialysis Patients","volume":"46","author":"Nalesso","year":"2020","journal-title":"Ultrasound Med. Biol."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/6\/792\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:12:30Z","timestamp":1774005150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/6\/792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["healthcare14060792"],"URL":"https:\/\/doi.org\/10.3390\/healthcare14060792","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}